Can bisphosphonate treatment be stopped in a growing child with skeletal fragility?

Author： Ward K.   Adams J.   Freemont T.   Mughal M.  

Publisher： Springer Publishing Company

ISSN： 0937-941X

Source： Osteoporosis International, Vol.18, Iss.8, 2007-08, pp. : 1137-1140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Obesity, the epidemic that CAN be stopped?

By  

JOURNAL OF ADVANCED NURSING, Vol. 71, Iss. 9, 2015-09 ,pp. : 1971-1972

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pathogenesis and Bisphosphonate Treatment of Skeletal Events and Bone Pain in Metastatic Cancer: Focus on Ibandronate

By  

Oncology Research and Treatment, Vol. 35, Iss. 6, 2012-05 ,pp. : 380-387

Karger

Access to resources Recommend Favorite

CHANGES IN SKELETAL MASS AND FRAGILITY WITH CASTRATION IN THE RAT: A MODEL OF OSTEOPOROSIS*

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 17, Iss. 2, 1969-02 ,pp. : 155-166

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bone safety of long-term bisphosphonate treatment

By Rodan Gideon   Reszka Alfred   Golub Ellis   Rizzoli René  

Current Medical Research and Opinion, Vol. 20, Iss. 8, 2004-08 ,pp. : 1291-1300

Informa Healthcare

Access to resources Recommend Favorite

Avascular Osteonecrosis of the Jaw as a Side Effect of Bisphosphonate Treatment

By  

Oncology Research and Treatment, Vol. 33, Iss. 6, 2010-05 ,pp. : 288-289

Karger

Access to resources Recommend Favorite